ElisaHelenIgnatiusMD

PubMed

• High-Dose Isoniazid Lacks EARLY Bactericidal Activity Against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized, Phase 2 Clinical Trial.
  Kamunkhwala Gausi, Elisa H Ignatius, Veronique De Jager, Caryn Upton, Soyeon Kim, Ashley McKhann, Laura Moran, Lubbe Wiesner, Florian von Groote-Bidlingmaier, Philip M...> ;American Journal of Respiratory and Critical Care Medicine. 2024 Apr 2
• Efficacies of three drug regimens containing omadacycline to treat Mycobacteroides abscessus disease.
  Binayak Rimal, Chandra M Panthi, Yi Xie, Daniel C Belz, Elisa H Ignatius, Christopher K Lippincott, Daniel H Deck, Alisa W Serio, Gyanu Lamichhane> ;Tuberculosis. 2024 May 1
• 1 citations
  Efficacy of Omadacycline-Containing Regimen in a Mouse Model of Pulmonary Mycobacteroides abscessus Disease.
  Binayak Rimal, Danielle A Nicklas, Chandra M Panthi, Christopher K Lippincott, Daniel C Belz, Elisa H Ignatius, Daniel H Deck, Alisa W Serio, Gyanu Lamichhane> ;Msphere. 2023 Apr 20
• 4 citations
  Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-Containing Regimens for Drug-Sensitive Tuberculosis: 12-Week Results.
  Kelly E Dooley, Bronwyn Hendricks, Nikhil Gupte, Grace Barnes, Kim Narunsky, Colleen Whitelaw, Tanya Smit, Elisa H Ignatius, Adine Friedman, Susan E Dorman, Rodney Dawson> ;American Journal of Respiratory and Critical Care Medicine. 2023 Apr 1
• 1 citations
  Pharmacokinetics of standard versus high-dose isoniazid for treatment of multidrug-resistant tuberculosis.
  Kamunkhwala Gausi, Maxwell Chirehwa, Elisa H Ignatius, Richard Court, Xin Sun, Laura Moran, Richard Hafner, Lubbe Wiesner, Susan L Rosenkranz, Veronique de Jager, Niha...> ;The Journal of Antimicrobial Chemotherapy. 2022 Aug 25
• 10 citations
  Nebulized Bacteriophage in a Patient With RefractoryLung Disease.
  Rebekah M Dedrick, Krista G Freeman, Jan A Nguyen, Asli Bahadirli-Talbott, Mitchell E Cardin, Madison Cristinziano, Bailey E Smith, Soowan Jeong, Elisa H Ignatius, Che...> ;Open Forum Infectious Diseases. 2022 Jul 1
• 11 citations
  A Semimechanistic Model of the Bactericidal Activity of High-Dose Isoniazid against Multidrug-Resistant Tuberculosis: Results from a Randomized Clinical Trial.
  Kamunkhwala Gausi, Elisa H. Ignatius, Xin Sun, Soyeon Kim, Laura Moran, Lubbe Wiesner, Florian von Groote-Bidlingmaier, Richard Hafner, Kathleen Donahue, Naadira Vanke...> ;American Journal of Respiratory and Critical Care Medicine. 2021 Aug 17
• 1 citations
  A leap forward in assessing host-directed therapies for tuberculosis.
  Elisa H. Ignatius, Kelly E. Dooley> ;The Lancet. Respiratory Medicine. 2021 Mar 16
• 1 citations
  Resistance-Conferring Mycobacterial Mutations and Quantification of Early Bactericidal Activity
  Solomon P. le Roux, Caryn Upton, Naadira Vanker, Kelly E. Dooley, Andreas H. Diacon, Sachiko Miyahara, Florian von Groote-Bidlingmaier, Xin Sun, Richard Hafner, Susan ...> ;American Journal of Respiratory and Critical Care Medicine. 2021 Mar 1
• 1 citations
  A validated liquid chromatography tandem mass spectrometry assay for the analysis of pretomanid in plasma samples from pulmonary tuberculosis patients
  Andisiwe Malo, Tracy Kellermann, Elisa H. Ignatius, Kelly E. Dooley, Rodney Dawson, Anton Joubert, Jennifer Norman, Sandra Castel, Lubbe Wiesner> ;Journal of Pharmaceutical and Biomedical Analysis. 2021 Feb 20
• 17 citations
  Tocilizumab for the Treatment of COVID-19 Among Hospitalized Patients: A Matched Retrospective Cohort Analysis
  Elisa H. Ignatius, Kunbo Wang, Andrew H. Karaba, Matthew L Robinson, Robin K. Avery, Paul W Blair, Natasha Chida, Tania Jain, Brent G. Petty, Zishan K. Siddiqui, Micha...> ;Open Forum Infectious Diseases. 2021 Jan 1
• 5 citations
  Are We There Yet? Short-Course Regimens in TB and HIV: From Prevention to Treatment of Latent to XDR TB
  Elisa H. Ignatius, Susan Swindells> ;Current HIV/AIDS Reports. 2020 Dec 1
• 12 citations
  Pretomanid Pharmacokinetics in the Presence of Rifamycins: Interim Results from a Randomized Trial among Patients with Tuberculosis.
  Elisa H. Ignatius, Mahmoud Tareq Abdelwahab, Bronwyn Hendricks, Nikhil Gupte, Kim Narunsky, Lubbe Wiesner, Grace L. Barnes, Rodney Dawson, Kelly E. Dooley, Paolo Denti> ;Antimicrobial Agents and Chemotherapy. 2021 Jan 20
• 2 citations
  Getting to the point in point-of-care diagnostics for tuberculosis
  Elisa H. Ignatius, Keira A. Cohen, William R. Bishai> ;The Journal of Clinical Investigation. 2020 Nov 2
• 8 citations
  PrEParing for long-acting injectable PrEP in the South: perspectives from healthcare providers in Georgia
  Casey D. Xavier Hall, Justin C Smith, Robert A Driggers, Bethany Stoller, Zara Khan, Jingjing Li, Elisa H. Ignatius, Aaron J Siegler> ;AIDS Care. 2021 Jun 3
• 1 citations
  Reply to Decroo et al.: High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis.
  Kelly E. Dooley, Sachiko Miyahara, Florian von Groote-Bidlingmaier, Xin Sun, Richard Hafner, Susan L. Rosenkranz, Elisa H. Ignatius, Eric L. Nuermberger, Laura Moran, ...> ;American Journal of Respiratory and Critical Care Medicine. 2020 Jun 15
• 27 citations
  Early Bactericidal Activity of Different Isoniazid Doses for Drug-Resistant Tuberculosis (INHindsight): A Randomized, Open-Label Clinical Trial
  Kelly E. Dooley, Sachiko Miyahara, Florian von Groote-Bidlingmaier, Xin Sun, Richard Hafner, Susan L. Rosenkranz, Elisa H. Ignatius, Eric L. Nuermberger, Laura Moran, ...> ;American Journal of Respiratory and Critical Care Medicine. 2020 May 29
• 28 citations
  New Drugs for the Treatment of Tuberculosis.
  Elisa H. Ignatius, Kelly E. Dooley> ;Clinics in Chest Medicine. 2019 Dec 1
• 172 citations
  Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study
  Elize Pietersen, Elisa Ignatius, Elizabeth M. Streicher, Barbara Lazaro Mastrapa, Xavier Padanilam, Anil Pooran, Motasim Badri, Maia Lesosky, Paul D. van Helden, Frede...> ;Lancet. 2014 Apr 5
• Join now to see all